English – Page 72 – TechStock²

CompoSecure stock drops 8% as Husky deal closes; GPGI ticker switch set for Jan. 23

NEW YORK, Jan 12, 2026, 15:44 EST — Regular session CompoSecure, Inc. (CMPO) shares dropped roughly 8% Monday after the metal payment-card maker announced it finalized its business combination with Husky Technologies and will rebrand as GPGI. The stock slid

12 January 2026

Business News·Company Updates·Financial Analysis·Stock Market

Marvell stock stalls even as chip ETFs rise — what’s moving MRVL now

New York, January 12, 2026, 15:38 EST — Regular session Marvell Technology shares barely moved Monday afternoon, trailing broader semiconductor gains. At 3:38 p.m. EST, the stock slipped slightly to $83.21. Meanwhile, the iShares Semiconductor ETF climbed roughly 0.7%, and

12 January 2026

Financial Analysis·Investing·Semiconductors·Stock Market·Technology News

Caterpillar stock hits a fresh record as Citi lifts target and traders look to CPI, earnings

New York, Jan 12, 2026, 15:37 EST — Regular session Caterpillar Inc shares hit an intraday high on Monday, outpacing a steady U.S. market as investors focused on major industrial stocks ahead of key data releases and the upcoming late-January

12 January 2026

Economic News·Financial Analysis·Investing·Stock Market

CrowdStrike stock slips on KeyBanc downgrade as 2026 security budget doubts surface

New York, Jan 12, 2026, 15:21 EST — Regular session CrowdStrike Holdings, Inc. shares dropped Monday following a downgrade by KeyBanc Capital Markets. The move adds pressure on the cybersecurity company’s stock, which had been factoring in steady spending and

12 January 2026

Cybersecurity·Financial Analysis·Investment News·Stock Market·Technology Stocks

Dave Inc stock drops nearly 9% as fintech lenders slide; CPI test looms for DAVE

New York, Jan 12, 2026, 15:40 ET — Regular session Shares of Dave Inc (DAVE.O) dropped 8.8% to $218.29 in late-afternoon trading Monday, after earlier fluctuating between $212.10 and $247.74. The fintech’s stock had closed Friday at $239.35, with roughly

12 January 2026

Economic Indicators·Financial News·Fintech·Investing·Stock Market

Arcutis Biotherapeutics stock slides after 2026 ZORYVE sales outlook; June FDA deadline in focus

New York, January 12, 2026, 15:41 ET — Regular session Shares of Arcutis Biotherapeutics dropped 8.7% on Monday, slipping $2.46 to $25.76, following the company’s update on its 2026 priorities. The dermatology drugmaker set a $455 million to $470 million

12 January 2026

Biotech·FDA Updates·Investment Analysis·Pharmaceuticals·Stock Market

Caris Life Sciences (CAI) stock drops on preliminary 2025 results, Everlywell cancer-screening deal

NEW YORK, Jan 12, 2026, 15:29 (EST) — Trading in the regular session. Caris Life Sciences shares dropped roughly 8.5% to $26.08 in afternoon trading, after fluctuating between $25.35 and $29.77 earlier today. The update comes amid J.P. Morgan Healthcare

12 January 2026

Biotechnology·Financial News·Healthcare Industry·Stock Market

HealthEquity stock slides nearly 10% after 2027 outlook; JPM conference is next test

New York, Jan 12, 2026, 15:31 EST — Regular session Shares of HealthEquity dropped roughly 10% in Monday afternoon trading following the benefits administrator’s cautious initial fiscal 2027 outlook. The stock last traded down $9.53 at $84.62, hitting a session

12 January 2026

Earnings Reports·Financial News·Investment Analysis·Stock Market

Credo Technology (CRDO) stock climbs as AI-chip trade stays hot; Needham conference next

NEW YORK, Jan 12, 2026, 15:19 EST — Regular session Shares of Credo Technology Group Holding Ltd climbed 3.1% to $155.10 in Monday afternoon trading, bouncing between $145.35 and $156.43 earlier. The Nasdaq-listed company, with a market cap near $32.5

12 January 2026

Artificial Intelligence·Financial News·Investing·Stock Market·Technology

Synchrony Financial stock slides on Trump’s 10% credit-card rate cap pitch — what investors watch next

New York, Jan 12, 2026, 3:33 PM EST — Regular session Shares of Synchrony Financial dropped sharply on Monday, tumbling 8.2% to $79.76 in afternoon trading. The slide followed President Donald Trump’s push for a one-year cap on credit-card interest

12 January 2026

Economic Policy·Financial News·Investment Strategies·Stock Market

Mesoblast (MESO) stock drops 11% as traders digest insider buy and Ryoncil sales backdrop

New York, Jan 12, 2026, 15:14 (EST) — Regular session Mesoblast Ltd’s shares on the U.S. market dropped roughly 11% Monday, sliding to $18.64 in afternoon trading after hitting $20.14 earlier. The Australian biotech’s stock has seen sharp swings since

12 January 2026

Biotech Industry·Insider Trading·Investment Insights·Stock Market News

Texas Instruments stock slips as chip ETF firms; investors eye Jan. 27 earnings amid Fed jitters

New York, Jan 12, 2026, 15:11 EST — Regular session. Texas Instruments shares slipped slightly on Monday afternoon, lagging behind the steadier semiconductor sector. The stock dipped roughly 0.2% to $189.85. The split matters since Texas Instruments serves as a

12 January 2026

Earnings Reports·Federal Reserve·Investment Analysis·Semiconductors·Stock Market